Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,509-2,520 of 10,612
Drug study icon
CompletedNCT00616798

RO4917838 for schizophrenia

This study is completed in the United States, in France, in Austria, .... It is testing RO4917838 for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States, France, Austria, ...
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
TerminatedNCT04951609

Seltorexant for depression

This study was terminated in the United States, in the United Kingdom, in Italy, .... It is testing seltorexant for depression.

In United States
DepressionDrugFrom 12 Years to 17 Years
Countries
United States, United Kingdom, Italy, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04533529

Seltorexant for depression

This study is completed in the United States, in Brazil, in Bulgaria, .... It is testing seltorexant for depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Brazil, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT04532749

Seltorexant for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing seltorexant for depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04513912

Seltorexant Compared to Quetiapine XR for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing Seltorexant Compared to Quetiapine XR for depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT07549581

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

This study is completed in the United States. It is testing SEP-380135 for depression.

In United States
Depression, Schizophrenia, ...DrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Schizophrenia, ...
Drug study icon
CompletedNCT00182078

Sertraline to Prevent PTSD

This study is completed in the United States. It focuses on PTSD.

In United States
PTSD, DepressionDrugFrom 6 Years to 20 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
PTSD, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.